{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:35:32Z","timestamp":1792758932564,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012082","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"reference-count":86,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012082.pub2","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T08:37:23Z","timestamp":1533285443000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews"],"prefix":"10.1002","volume":"2018","author":[{"given":"Patricia M","family":"Fortin","sequence":"first","affiliation":[{"name":"5639 Gowland Rd. Sechelt BC Canada V0N 3A8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"University of Oxford; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS); Botnar Research Centre, Windmill Road Oxford Oxfordshire UK OX3 7LD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise J","family":"Estcourt","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0001|cit1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004198.pub2","article-title":"Treatments for priapism in boys and men with sickle cell disease","author":"Chinegwundoh","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub2-BIB0002|cit2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007843.pub3","article-title":"Blood transfusions for treating acute chest syndrome in people with sickle cell disease","author":"Dastgiri","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub2-BIB0003|cit3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008360.pub4","article-title":"Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease","author":"Estcourt","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0004|cit4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003149.pub3","article-title":"Preoperative blood transfusions for sickle cell disease","author":"Estcourt","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub2-BIB0005|cit5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003146.pub3","article-title":"Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease","author":"Estcourt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub2-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012389.pub2","article-title":"Interventions for preventing silent cerebral infarcts in people with sickle cell disease","author":"Estcourt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub2-BIB0007|cit7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006786.pub2","article-title":"Interventions for treating painful sickle cell crisis during pregnancy","author":"Mart\u00ed-Carvajal","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012082.pub2-BIB0008|cit8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008394.pub3","article-title":"Interventions for treating leg ulcers in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0009|cit9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010985.pub2","article-title":"Interventions for treating intrahepatic cholestasis in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004344.pub6","article-title":"Treatment for avascular necrosis of bone in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012082.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010378.pub3","article-title":"Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy","author":"Okusanya","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004448.pub5","article-title":"Phytomedicines (medicines derived from plants) for sickle cell disease","author":"Oniyangi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007001.pub4","article-title":"Hematopoietic stem cell transplantation for people with sickle cell disease","author":"Oringanje","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012082.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003425.pub3","article-title":"Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease","author":"Owusu-Ofori","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub2-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012380","article-title":"Interventions for chronic kidney disease in people with sickle cell disease","author":"Roy","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006111.pub2","article-title":"Piracetam for reducing the incidence of painful sickle cell disease crises","author":"Al Hajeri","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007843.pub2","article-title":"Blood transfusions for treating acute chest syndrome in people with sickle cell disease","author":"Alhashimi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012082.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002042.pub4","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","author":"Carson","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004222.pub2","article-title":"Treatment for women with postpartum iron deficiency anaemia","author":"Dodd","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002202","article-title":"Hydroxyurea for sickle cell disease","author":"Jones","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003733.pub3","article-title":"Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease","author":"Knight-Madden","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012082.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005598.pub3","article-title":"Antibiotics for treating community acquired pneumonia in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006110.pub4","article-title":"Antibiotics for treating acute chest syndrome in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001475","article-title":"Blood transfusion for treating malarial anaemia","author":"Meremikwu","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub2-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003426.pub4","article-title":"Drugs for preventing red blood cell dehydration in people with sickle cell disease","author":"Nagalla","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005406.pub4","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","author":"Okomo","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub2-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010155.pub2","article-title":"Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease","author":"Zuuren","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD012082.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/tropej\/fmh097","article-title":"Clinical evaluation of extract of Cajanuscajan (Ciklavit) in sickle cell anaemia","volume":"51","author":"Akinsulie","year":"2005","journal-title":"Journal of Tropical Paediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0032|cit32","first-page":"164","article-title":"Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anemia","volume":"28","author":"Al-Jaouni","year":"2006","journal-title":"Bahrain Medical Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"e2013062","DOI":"10.4084\/mjhid.2013.062","article-title":"Sickle cell disease: management options and challenges in developing countries","volume":"5","author":"Ansong","year":"2013","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jrsm.1229","article-title":"Risk of bias in overviews of reviews: a scoping review of methodological guidance and four-item checklist","volume":"8","author":"Ballard","year":"2017","journal-title":"Research Synthesis Methods"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE Guidelines 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0035-9203(87)90049-6","article-title":"Topical antibiotics in chronic sickle cell leg ulcers","volume":"81","author":"Baum","year":"1987","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/asheducation-2013.1.439","article-title":"Transfusion therapy for sickle cell disease: a balancing act","volume":"2013","author":"Chou","year":"2013","journal-title":"Hematology"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0040|cit40","unstructured":"US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute Expert Panel Report 2014 Evidence-based management of sickle cell disease: Expert Panel Report, 2014 http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/sickle-cell-disease-guidelines"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9343(98)00056-4","article-title":"A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia","volume":"104","author":"Foucan","year":"1998","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"Journal of Clinical Investigation"},{"issue":"7526","key":"10.1002\/14651858.CD012082.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/515S1a","article-title":"Sickle-cell disease","volume":"515","author":"Gravitz","year":"2014","journal-title":"Nature"},{"issue":"6S4","key":"10.1002\/14651858.CD012082.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa. A neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0045|cit45","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0046|cit46","unstructured":"Higgins JPT Green S (editors) Chapter 22: Overviews of reviews. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines","volume":"21","author":"Josephson","year":"2007","journal-title":"Transfusion Medicine Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ajh.20642","article-title":"Cerebrovascular disease associated with sickle cell pulmonary hypertension","volume":"81","author":"Kato","year":"2006","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1447-52","DOI":"10.1056\/NEJM198812013192204","article-title":"Prophylactic red-cell transfusions in pregnant patients with sickle cell disease","volume":"319","author":"Koshy","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0052|cit52","first-page":"121","article-title":"A randomized controlled trial of solcoseryl and duoderm in chronic sickle cell ulcers","volume":"42","author":"Grenade","year":"1993","journal-title":"West Indian Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2141.2010.08395.x","article-title":"A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers","volume":"151","author":"McMahon","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"12","key":"10.1002\/14651858.CD012082.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2106\/00004623-200612000-00003","article-title":"Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment","volume":"88","author":"Neumayr","year":"2006","journal-title":"Journal of Bone and Joint Surgery"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0055|cit55","unstructured":"NICE (National Institute for Health and Care Excellence) Sickle cell disease http:\/\/cks.nice.org.uk\/sickle-cell-disease#!backgroundsub:3"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0056|cit56","unstructured":"Ohene-Frempong K Sickle cell disease in the United Statesof America and Africa Hematology (American Society of Hematology Education Program). American Society of Hematology 1999 64 72"},{"issue":"9861","key":"10.1002\/14651858.CD012082.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2012","journal-title":"Lancet"},{"issue":"16","key":"10.1002\/14651858.CD012082.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle Cell Disease","volume":"376","author":"Piel","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jclinepi.2014.12.009","article-title":"Systematic review found AMSTAR, but not R(evised)-AMSTAR to have good measurement properties","volume":"68","author":"Pieper","year":"2015","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7526","key":"10.1002\/14651858.CD012082.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0061|cit61","first-page":"447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"1","author":"Porter","year":"2013","journal-title":"ASH Education Program Book"},{"issue":"9757","key":"10.1002\/14651858.CD012082.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0063|cit63","unstructured":"The Nordic Cochrane Centre Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"e100516","DOI":"10.1371\/journal.pone.0100516","article-title":"The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival","volume":"9","author":"Rumaney","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3181c70e14","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease","volume":"339","author":"Scheunemann","year":"2010","journal-title":"American Journal of the Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1537-2995.1987.27387235626.x","article-title":"Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion","volume":"27","author":"Schmalzer","year":"1987","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0067|cit67","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0068|cit68","first-page":"164","article-title":"Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration","volume":"26","author":"Serjeant","year":"1977","journal-title":"West Indian Medical Journal"},{"issue":"8467","key":"10.1002\/14651858.CD012082.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease","volume":"2","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0190-9622(97)70156-7","article-title":"Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: a pilot study","volume":"37","author":"Serjeant","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Shea BJ Grimshaw JM Wells GA Boers M Andersson N Hamel C Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews BMC Medical Research Methodology 2007","DOI":"10.1186\/1471-2288-7-10"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"British Journal of Haematology"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"American Journal of Hematology"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2141.2012.09105.x","article-title":"Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE).","volume":"157","author":"Styles","year":"2012","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/asheducation-2006.1.48","article-title":"Red cell exchange in sickle cell disease","volume":"2006","author":"Swerdlow","year":"2006","journal-title":"Hematology"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2141-9248.105655","article-title":"Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria","volume":"2","author":"Ubesie","year":"2012","journal-title":"Annals of Medical and Health Sciences Research"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimes in the perioperative management of sickle cell disease","volume":"333","author":"Vichinsky","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5664\/jcsm.26805","article-title":"A patient with sickle cell disease and a low baseline sleeping oxygen saturation","volume":"3","author":"Wagner","year":"2007","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1078\/0944-7113-00040","article-title":"Double-blind, placebo controlled,randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder","volume":"8","author":"Wambebe","year":"2001","journal-title":"Phytomedicine"},{"issue":"9778","key":"10.1002\/14651858.CD012082.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"issue":"17","key":"10.1002\/14651858.CD012082.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"issue":"10019","key":"10.1002\/14651858.CD012082.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1182\/blood.V84.6.1775.1775","article-title":"Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group","volume":"84","author":"Wethers","year":"1994","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD012082.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012082.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"i157","DOI":"10.1136\/bmj.i157","article-title":"PRISMA harms checklist: improving harms reporting in systematic reviews","volume":"352","author":"Zorzela","year":"2016","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1002\/14651858.cd012082.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012082.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:02:46Z","timestamp":1628535766000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012082.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012082.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}